NCT02939118已完成不适用
A One-Year, Multicenter, Observational, Follow-up Safety Study in Subjects Previously Implanted With VC-01™ Combination Product
ViaCyte0 个研究点目标入组 51 人开始时间: 2016年11月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 51
- 主要终点
- Incidence of adverse events reported during the study.
研究概览
简要总结
The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Previous implantation of VC-01™ combination product with subsequent explantation of all VC-01 units.
排除标准
- •There are no exclusion criteria for this trial.
结局指标
主要结局
Incidence of adverse events reported during the study.
时间窗: 12 months
次要结局
未报告次要终点
研究者
相似试验
招募中
不适用
Bactiseal Catheter Safety Registry StudyHydrocephalusNCT06276543Integra LifeSciences Corporation200
已完成
不适用
Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopneaObstructive Sleep Apnea HypopneaObstructive Sleep ApneaOSAHNCT00849043Ventus Medical, Inc.65
Enrolling By Invitation
2 期
Long-term Follow-Up Study of RGX-314 and Fellow Eye SubstudyNeovascular Age-related Macular DegenerationWet Macular DegenerationNCT03999801AbbVie865
Enrolling By Invitation
2 期
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMDNeovascular Age-Related Macular Degeneration (nAMD)Gene TherapyWet AMDwAMDnAMDNCT05210803AbbVie116
Enrolling By Invitation
2 期
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic RetinopathyDiabetic Retinopathy, DRNCT05296447AbbVie100